Your browser doesn't support javascript.
loading
Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis.
Li, Qian; Qiao, Ju; Jin, Hongzhong; Chen, Benchao; He, Zhimei; Wang, Guoqin; Ni, Xiang; Wang, Max; Xia, Michelle; Li, Baiyong; Chen, Rui; Hu, Pei.
Afiliación
  • Li Q; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Chinese Academy o
  • Qiao J; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
  • Jin H; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
  • Chen B; Akeso Biopharma, Inc, Zhongshan, China.
  • He Z; Akeso Biopharma, Inc, Zhongshan, China.
  • Wang G; Akeso Biopharma, Inc, Zhongshan, China.
  • Ni X; Akeso Biopharma, Inc, Zhongshan, China.
  • Wang M; Akeso Biopharma, Inc, Zhongshan, China.
  • Xia M; Akeso Biopharma, Inc, Zhongshan, China.
  • Li B; Akeso Biopharma, Inc, Zhongshan, China.
  • Chen R; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Chinese Academy o
  • Hu P; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigation for Innovative Drugs, Chinese Academy o
Front Pharmacol ; 13: 966176, 2022.
Article en En | MEDLINE | ID: mdl-36052126
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article